Company Data
Curis Inc.
Ticker
CRIS
Current Price
$1.705 9.29%
Market Cap
$21.3M
Price Target
Refer to Report
Volume
195.9K
52wk Range
$1.02 - $8.29
Overview
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.